Contact this trialFirst, we need to learn more about you.
Antiplatelet Agent
Low-Dose vs Standard-Dose Aspirin for Head/Neck Vessel Injury
Recruiting3 awardsPhase 4
Loma Linda, California
This trial will compare Aspirin 81 mg and 325 mg to see if one is better at preventing strokes in those with head/neck vessel injury, with an eye to any increased risk of bleeding.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service